In order to further strengthen the quality management of drug distribution, and ensure drug safety, the Decision on Amending Good Supply Practice for Pharmaceutical Products was adopted at the executive meeting of China Food and Drug Administration (CFDA) on June 30, 2016, and shall go into effect as of the date of promulgation. CFDA issued the newly amended Good Supply Practice for Pharmaceutical Products on July 20, 2016. 

For detail information, please visit the CFDA Chinese website: http://www.sda.gov.cn/WS01/CL0053/159780.html